Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. FDA Refuses To Release Names Of Chinese Heparin Suppliers

This article was originally published in PharmAsia News

Executive Summary

The U.S. FDA refuses to supply a congressional committee a list of the Chinese companies that supply the active ingredient heparin used in blood-clotting drugs. Congressional investigators want to explore the agency's handling of drug imports in the wake of the tainted heparin problem believed the cause of several U.S. deaths. The FDA said it cannot release the names of the Chinese companies because it has confidentiality agreements with drug manufacturers. Members of Congress believe Chinese drug makers did not cooperate fully with the U.S. FDA's own investigation. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts